Company Overview and News
2018-10-01 seekingalpha - 7
Science and art, or if you prefer skill and luck, are both needed for consistent success in short-term trading to long-term investing. Some deny this and say it's all math, claiming that markets always represent fair value. If so, high-frequency trading algo-bot scalpers will always win, meaning people can never outsmart to beat the market as all opportunities and risks are fully discounted into prices.
STZ.B TWX MEAOF BTR AMZN AABA LVNSF FQM NDM MISVF HVBTF GDX AXXDF STZ TWC PRU SLV BABA ATUSF AAUKF VZ BALMF BB FB DB KGI.DB NFLX GOOG GLD TLRY ALS WEED NAK PMNXF AAPL FQVLF PRU ADV BLKCF DIS KL GDXJ EGO FM KGI MSV KGI.DB.A AAL CGC NDMWF ELD BAR NGLOY
2018-10-01 sec.gov - 24
JA Filed by Filing Services Canada Inc. 403-717-3898
2018-09-25 seekingalpha - 1
Another CEO is having a shot at fixing New Gold. Unfortunately, things have gone from bad to worse since the last iteration on this theme. Welcome to this week's
OCANF CAT IVN LIACF TMMFF NGD NSU BTR AMGGF IAG IPMLF ABX III NGD GPL OKSWF EQXGF RGLD ATUSF MNIKF AMLM OSKGF VTT RGL HRT VDTAF HRTFF BDREF CGOOF KGI.DB NGDAF CG VITFF TREVF AGI CAGDF OR RIC CSFFF CS KL CORVF EGO RIC ABX KOR KGI KGI.DB.A AGI BDR VIT IVPAF TMR ELD
Back in June, I wrote an update on Harmony Gold Mining (HMY) following the company's equity raise near yearly lows. Currently, I'm intrigued by the possibility of a rebound in gold mining stocks as gold tries to get some upside from the $1,200 level (I've already laid out my views on Barrick Gold (ABX) (here), Agnico Eagle Mines (AEM) (here), Newmont Mining (NEM) (here), Yamana Gold (AUY) (here), Eldorado Gold (EGO) (here), Goldcorp (here), Kinross Gold (here)).
HMY ABX ELD KGC AUY NEM YRI K AEM HGMCF EGO ABX
VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- NV Gold Corporation (TSX.V: NVX; OTC Pink: NVGLF) (“NV Gold” or the “Company”) announces that it has appointed Mr. Peter A. Ball as its President and COO. Mr. Ball has been a director of NV Gold since September 29, 2016 and will continue as a director. John Watson, NV Gold’s former President and CEO and a director, will continue as a director and officer of the Company in the role of Chairman and CEO.
RGCTF NVX CBGDF RGC ANARF ELD ADI AGXMF NVGLF EGO
Hellas Gold S.A. has filed a non-judicial request for payment of approximately €750 million with the Hellenic Republic, arising from delays in the issuance of permits for the Skouries project.
ICGQF ICG ELD OUKPF EGO
2018-09-18 sec.gov - 1
JA Filed by Filing Services Canada Inc. 403-717-3898
Sept 18 (Reuters) - Canada’s main stock index edged higher on Tuesday, boosted by gains in energy companies as oil prices rose on signs that OPEC may not raise output to address shrinking supplies from Iran.
NGD ELD NGDAF FQVLF FQM NGD EGO
(Reuters) - Eldorado Gold said on Tuesday it would seek a compensation of 750 million euros ($877.35 million)from Greece for damages suffered by the Canadian miner due to delays in the issuance of permits for its Skouries project.
ATHENS, Greece (AP) — Canadian gold mining firm Eldorado Gold is seeking 750 million euros ($875 million) in damages from the Greek state over delays in permits for mining work in the north of the country.
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to EGO / Eldorado Gold Corporation on message board site Silicon Investor.
as of ET